Risk Factors Update Summary
- The company received a letter from Nasdaq indicating non-compliance with the $1.00 minimum bid price requirement.
- Political, economic, and military instability in Israel may impede operations, with ongoing conflicts and terrorism.
- Failure to regain compliance with Nasdaq listing requirements may lead to delisting and impact stock price.
- The company faces cybersecurity risks, with potential unauthorized access to data and information loss.
- Delaware law provisions could deter takeovers, affecting stockholders' ability to approve transactions.
- The FDA voted against the effectiveness of NurOwn for mild to moderate ALS, impacting future approvals.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1137883&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.